RVL Pharmaceuticals plc (RVLPQ)
OTCMKTS: RVLPQ · Delayed Price · USD
0.0005
+0.0004 (400.00%)
Jul 16, 2024, 4:00 PM EDT - Market closed
RVL Pharmaceuticals Employees
RVL Pharmaceuticals had 125 employees as of December 31, 2022. The number of employees decreased by 31 or -19.87% compared to the previous year.
Employees
125
Change (1Y)
-31
Growth (1Y)
-19.87%
Revenue / Employee
$295,352
Profits / Employee
-$546,128
Market Cap
55.70K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 125 | -31 | -19.87% |
| Dec 31, 2021 | 156 | -146 | -48.34% |
| Dec 31, 2020 | 302 | -77 | -20.32% |
| Dec 31, 2019 | 379 | -87 | -18.67% |
| Dec 31, 2018 | 466 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
RVLPQ News
- 8 months ago - RVL Completes Financial Restructuring - GlobeNewsWire
- 10 months ago - RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries - GlobeNewsWire
- 1 year ago - RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference - GlobeNewsWire
- 1 year ago - RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 1 year ago - RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review - GlobeNewsWire
- 1 year ago - RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update - GlobeNewsWire
- 1 year ago - RVL Pharmaceuticals plc Provides Business Update - GlobeNewsWire
- 1 year ago - RVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General Meeting - GlobeNewsWire